AIMS We assessed the performance of modelsf (risk scores) for predicting recurrence of atrial fibrillation (AF) in patients who have undergone catheter ablation. METHODS AND RESULTS Systematic searches of bibliographic databases were conducted (November 2018). Studies were eligible for inclusion if they reported the development, validation, or impact assessment of a model for predicting AF recurrence after ablation. Model performance (discrimination and calibration) measures were extracted. The Prediction Study Risk of Bias Assessment Tool (PROBAST) was used to assess risk of bias. Meta-analysis was not feasible due to clinical and methodological differences between studies, but c-statistics were presented in forest plots. Thirty-t...
Freedom from atrial fibrillation (AF) at 1 year can be achieved in 50-70% of patients undergoing cat...
Aims: The aims of this study were to determine the rate and the predictors of early recurrences of a...
Background: Catheter ablation (CA) is a well-known treatment option for patients with symptomatic dr...
Abstract Catheter ablation (CA) for atrial fibrillation (AF) has emerged as a widespread first or se...
Context: Transcatheter ablation of atrial fibrillation (AF) has undergone important development, wit...
Background: A significant number of patients experience recurrent atrial fibrillation (AF) after abl...
Abstract Introduction There are several prognostic scores for the assessment of risk of atrial fibri...
Single-procedure catheter ablation success rate is as low as 52% in atrial fibrillation (AF) patient...
Methods for characterization of atrial fibrillation (AF) episode patterns have been introduced witho...
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and is associated with sign...
Background and Objectives: Atrial fibrillation recurrences (AFR) after radiofrequency catheter ablat...
AIMS Freedom from atrial fibrillation (AF) at 1 year can be achieved in 50-70% of patients underg...
Aims: To evaluate the long-term outcome of patients with paroxysmal atrial fibrillation (AF) undergo...
Various treatment methods have been used for atrial fibrillation (AF), which has long been a cause o...
Introduction Dozens of multivariable prediction models for atrial fibrillation after cardiac surger...
Freedom from atrial fibrillation (AF) at 1 year can be achieved in 50-70% of patients undergoing cat...
Aims: The aims of this study were to determine the rate and the predictors of early recurrences of a...
Background: Catheter ablation (CA) is a well-known treatment option for patients with symptomatic dr...
Abstract Catheter ablation (CA) for atrial fibrillation (AF) has emerged as a widespread first or se...
Context: Transcatheter ablation of atrial fibrillation (AF) has undergone important development, wit...
Background: A significant number of patients experience recurrent atrial fibrillation (AF) after abl...
Abstract Introduction There are several prognostic scores for the assessment of risk of atrial fibri...
Single-procedure catheter ablation success rate is as low as 52% in atrial fibrillation (AF) patient...
Methods for characterization of atrial fibrillation (AF) episode patterns have been introduced witho...
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and is associated with sign...
Background and Objectives: Atrial fibrillation recurrences (AFR) after radiofrequency catheter ablat...
AIMS Freedom from atrial fibrillation (AF) at 1 year can be achieved in 50-70% of patients underg...
Aims: To evaluate the long-term outcome of patients with paroxysmal atrial fibrillation (AF) undergo...
Various treatment methods have been used for atrial fibrillation (AF), which has long been a cause o...
Introduction Dozens of multivariable prediction models for atrial fibrillation after cardiac surger...
Freedom from atrial fibrillation (AF) at 1 year can be achieved in 50-70% of patients undergoing cat...
Aims: The aims of this study were to determine the rate and the predictors of early recurrences of a...
Background: Catheter ablation (CA) is a well-known treatment option for patients with symptomatic dr...